| Year |
Citation |
Score |
| 2020 |
Ethier SP, Guest ST, Garrett-Mayer E, Armeson K, Wilson RC, Duchinski K, Couch D, Gray JW, Kappler C. Development and implementation of the SUM breast cancer cell line functional genomics knowledge base. Npj Breast Cancer. 6: 30. PMID 32715085 DOI: 10.1038/s41523-020-0173-z |
0.438 |
|
| 2020 |
Ethier SP, Duchinsky K, Couch D. Abstract P4-05-13: The SUM breast cancer cell line knowledge base (SLKBase): A knowledge base and functional genomics platform for breast cancer cell lines Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P4-05-13 |
0.501 |
|
| 2019 |
Giordano A, Liu Y, Armeson K, Park Y, Ridinger M, Erlander M, Reuben J, Britten C, Kappler C, Yeh E, Ethier S. Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer. Plos One. 14: e0224420. PMID 31751384 DOI: 10.1371/Journal.Pone.0224420 |
0.573 |
|
| 2019 |
Rutkovsky AC, Yeh ES, Guest ST, Findlay VJ, Muise-Helmericks RC, Armeson K, Ethier SP. Eukaryotic initiation factor 4E-binding protein as an oncogene in breast cancer. Bmc Cancer. 19: 491. PMID 31122207 DOI: 10.1186/S12885-019-5667-4 |
0.551 |
|
| 2019 |
Giordano A, Liu Y, Armeson K, Britten C, Kappler C, Ethier S. Abstract P5-03-03: Polo-like Kinase 1 (PLK1) inhibition synergizes with docetaxel in basal breast cancer cells Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P5-03-03 |
0.588 |
|
| 2019 |
Giordano A, Liu Y, Kappler C, Park Y, Yeh E, Erlander M, Ethier S. Polo-like kinase 1 inhibitor onvansertib synergizes with paclitaxel in breast cancer carrying p53 mutation Annals of Oncology. 30. DOI: 10.1093/Annonc/Mdz242.044 |
0.543 |
|
| 2018 |
Homer-Bouthiette C, Zhao Y, Shunkwiler LB, Van Peel B, Garrett-Mayer E, Baird RC, Rissman AI, Guest ST, Ethier SP, John MC, Powers PA, Haag JD, Gould MN, Smits BMG. Deletion of the murine ortholog of the 8q24 gene desert has anti-cancer effects in transgenic mammary cancer models. Bmc Cancer. 18: 1233. PMID 30526553 DOI: 10.1186/S12885-018-5109-8 |
0.489 |
|
| 2018 |
Carrell RK, Stanton RA, Ethier SP, LaRue AC, Soloff AC. ICOSL-augmented adenoviral-based vaccination induces a bipolar Th17/Th1 T cell response against unglycosylated MUC1 antigen. Vaccine. PMID 30219366 DOI: 10.1016/J.Vaccine.2018.09.010 |
0.304 |
|
| 2018 |
Sun B, Wang G, Liu H, Liu P, Twal WO, Cheung H, Carroll SL, Ethier SP, Mevers EE, Clardy J, Roberts T, Chen C, Li Q, Wang L, Yang M, et al. Oridonin inhibits aberrant AKT activation in breast cancer. Oncotarget. 9: 23878-23889. PMID 29844859 DOI: 10.18632/Oncotarget.24378 |
0.55 |
|
| 2017 |
Yang A, Qin S, Schulte BA, Ethier SP, Tew KD, Wang GY. MYC Inhibition depletes cancer stem-like cells in triple-negative breast cancer. Cancer Research. PMID 28951456 DOI: 10.1158/0008-5472.Can-16-3452 |
0.51 |
|
| 2017 |
Turner-Ivey B, Smith EL, Rutkovsky AC, Spruill LS, Mills JN, Ethier SP. Development of mammary hyperplasia, dysplasia, and invasive ductal carcinoma in transgenic mice expressing the 8p11 amplicon oncogene NSD3. Breast Cancer Research and Treatment. PMID 28484924 DOI: 10.1007/S10549-017-4258-9 |
0.441 |
|
| 2017 |
Mills JN, Ethier SP. Abstract 2405: The 8p11 amplicon oncogenes ASH2L and NSD3 alter the epigenomic landscape and provide the foundation for novel application of epigenetic therapy in luminal B breast cancers Cancer Research. 77: 2405-2405. DOI: 10.1158/1538-7445.Am2017-2405 |
0.441 |
|
| 2017 |
Kratche Z, Adams M, Wilson R, Ethier S, Guest S. Abstract 2314: Novel BH3 mimetic based therapeutic strategies for the treatment of breast cancer Cancer Research. 77: 2314-2314. DOI: 10.1158/1538-7445.Am2017-2314 |
0.469 |
|
| 2017 |
Yang A, He X, Schulte BA, Carroll SL, Ethier SP, Wang GY. Abstract 1919: Twist1 modulates paclitaxel-induced cancer stem cell enrichment in triple-negative breast cancer Cancer Research. 77: 1919-1919. DOI: 10.1158/1538-7445.Am2017-1919 |
0.562 |
|
| 2017 |
Smith EL, Kappler CS, Ethier SP. Abstract 1339: Role of PTEN loss in basal-like 2 triple negative breast cancer Cancer Research. 77: 1339-1339. DOI: 10.1158/1538-7445.Am2017-1339 |
0.604 |
|
| 2016 |
Allaoui R, Bergenfelz C, Mohlin S, Hagerling C, Salari K, Werb Z, Anderson RL, Ethier SP, Jirström K, Påhlman S, Bexell D, Tahin B, Johansson ME, Larsson C, Leandersson K. Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers. Nature Communications. 7: 13050. PMID 27725631 DOI: 10.1038/Ncomms13050 |
0.577 |
|
| 2016 |
Cichon MA, Moruzzi ME, Shqau TA, Miller E, Mehner C, Ethier SP, Copland JA, Radisky ES, Radisky DC. MYC is a crucial mediator of TGFβ-induced invasion in basal breast cancer. Cancer Research. PMID 27197167 DOI: 10.1158/0008-5472.Can-15-3465 |
0.575 |
|
| 2016 |
Guest ST, Kratche ZR, Irish JC, Wilson RC, Haddad R, Gray JW, Garrett-Mayer E, Ethier SP. Functional oncogene signatures guide rationally designed combination therapies to synergistically induce breast cancer cell death. Oncotarget. PMID 27153554 DOI: 10.18632/Oncotarget.9147 |
0.508 |
|
| 2016 |
Irish JC, Mills JN, Turner-Ivey B, Wilson RC, Guest ST, Rutkovsky A, Dombkowski A, Kappler CS, Hardiman G, Ethier SP. Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over-expression in breast cancer. Molecular Oncology. PMID 27005559 DOI: 10.1016/J.Molonc.2016.02.003 |
0.579 |
|
| 2016 |
Ethier S, Irish J, Mills J, Ivey B, Hardiam G, Wilson R, Domkowski A, Guest S. Abstract P6-03-04: Amplification of the WHSC1L1 oncogene regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over expression in breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P6-03-04 |
0.597 |
|
| 2016 |
Mills JN, Irish J, Turner-Ivey B, Ethier SP. Abstract B05: WHSC1L1 and estrogen-independent activation of estrogen receptor-alpha (ERα) in 8p11 amplicon-bearing cell lines Cancer Research. 76. DOI: 10.1158/1538-7445.Chromepi15-B05 |
0.556 |
|
| 2016 |
LaRue AC, Carrell R, McDonald LT, Russell DA, Ethier SP, Soloff AC. Abstract LB-092: Induction of IL-17-mediated cellular immunity targeting MUC1 through vaccination Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-092 |
0.326 |
|
| 2016 |
Kappler CS, Smith EL, Ethier S. Abstract 4596: Regulation of epidermal growth factor receptor signaling in triple-negative breast cancer Cancer Research. 76: 4596-4596. DOI: 10.1158/1538-7445.Am2016-4596 |
0.552 |
|
| 2015 |
Duckworth C, Zhang L, Carroll SL, Ethier SP, Cheung HW. Overexpression of GAB2 in ovarian cancer cells promotes tumor growth and angiogenesis by upregulating chemokine expression. Oncogene. PMID 26657155 DOI: 10.1038/Onc.2015.472 |
0.53 |
|
| 2015 |
Mehmeti M, Allaoui R, Bergenfelz C, Saal LH, Ethier SP, Johansson ME, Jirström K, Leandersson K. Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer. Breast Cancer Research : Bcr. 17: 130. PMID 26392082 DOI: 10.1186/S13058-015-0640-X |
0.393 |
|
| 2015 |
Williams CB, Soloff AC, Ethier SP, Yeh ES. Perspectives on Epidermal Growth Factor Receptor Regulation in Triple-Negative Breast Cancer: Ligand-Mediated Mechanisms of Receptor Regulation and Potential for Clinical Targeting. Advances in Cancer Research. 127: 253-81. PMID 26093903 DOI: 10.1016/Bs.Acr.2015.04.008 |
0.532 |
|
| 2015 |
Freedman LP, Gibson MC, Ethier SP, Soule HR, Neve RM, Reid YA. Reproducibility: changing the policies and culture of cell line authentication. Nature Methods. 12: 493-7. PMID 26020501 DOI: 10.1038/Nmeth.3403 |
0.339 |
|
| 2015 |
Guest ST, Kratche ZR, Bollig-Fischer A, Haddad R, Ethier SP. Two members of the TRiC chaperonin complex, CCT2 and TCP1 are essential for survival of breast cancer cells and are linked to driving oncogenes. Experimental Cell Research. 332: 223-35. PMID 25704758 DOI: 10.1016/J.Yexcr.2015.02.005 |
0.565 |
|
| 2015 |
Kappler CS, Guest ST, Irish JC, Garrett-Mayer E, Kratche Z, Wilson RC, Ethier SP. Oncogenic signaling in amphiregulin and EGFR-expressing PTEN-null human breast cancer. Molecular Oncology. 9: 527-43. PMID 25454348 DOI: 10.1016/J.Molonc.2014.10.006 |
0.525 |
|
| 2015 |
Kappler CS, Guest ST, Smith EL, Irish JC, Garrett-Mayer E, Kratche Z, Ethier S. Abstract 1949: Oncogenic signaling in amphiregulin- and EGFR-expressing PTEN-null human breast cancer Cancer Research. 75: 1949-1949. DOI: 10.1158/1538-7445.Am2015-1949 |
0.562 |
|
| 2015 |
Guest S, Kratche Z, Irish J, Bollig-Fischer A, Garrett-Mayer E, Ethier S. Abstract 1116: Oncogene signatures identify novel therapeutic targets and combinatorial strategies in breast cancer Cancer Research. 75: 1116-1116. DOI: 10.1158/1538-7445.Am2015-1116 |
0.48 |
|
| 2014 |
Findlay VJ, Wang C, Nogueira LM, Hurst K, Quirk D, Ethier SP, Staveley O'Carroll KF, Watson DK, Camp ER. SNAI2 modulates colorectal cancer 5-fluorouracil sensitivity through miR145 repression. Molecular Cancer Therapeutics. 13: 2713-26. PMID 25249558 DOI: 10.1158/1535-7163.Mct-14-0207 |
0.348 |
|
| 2014 |
Turner-Ivey B, Guest ST, Irish JC, Kappler CS, Garrett-Mayer E, Wilson RC, Ethier SP. KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer. Neoplasia (New York, N.Y.). 16: 644-55. PMID 25220592 DOI: 10.1016/J.Neo.2014.07.007 |
0.594 |
|
| 2014 |
Irish JC, Rutkovsky A, Ethier SP. Abstract 5148: Overexpression of histone methyltransferase WHSC1L1 regulates expression of ER-alpha in SUM44 breast cancer cells Cancer Research. 74: 5148-5148. DOI: 10.1158/1538-7445.Am2014-5148 |
0.587 |
|
| 2014 |
Ivey BT, Guest S, Ethier SP. Abstract 5135: A chromatin modifier from the 8p11 amplicon in luminal breast cancer Cancer Research. 74: 5135-5135. DOI: 10.1158/1538-7445.Am2014-5135 |
0.607 |
|
| 2014 |
Guest S, Irish J, Kratche Z, Garrett-Mayer E, Wilson R, Ethier S. Abstract 440: The TRiC chaperonin in breast cancer cell growth, survival and response to taxane therapy Cancer Research. 74: 440-440. DOI: 10.1158/1538-7445.Am2014-440 |
0.602 |
|
| 2014 |
Kappler C, Wilson R, Varughese B, Ethier SP. Abstract 3297: PTEN loss enhances amphiregulin-specific signaling and gene expression in triple-negative breast cancer Cancer Research. 74: 3297-3297. DOI: 10.1158/1538-7445.Am2014-3297 |
0.591 |
|
| 2013 |
Timmerman LA, Holton T, Yuneva M, Louie RJ, Padró M, Daemen A, Hu M, Chan DA, Ethier SP, van 't Veer LJ, Polyak K, McCormick F, Gray JW. Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target. Cancer Cell. 24: 450-65. PMID 24094812 DOI: 10.1016/J.Ccr.2013.08.020 |
0.478 |
|
| 2013 |
Kappler CS, Ethier SP. Abstract 530: Inhibition of amphiregulin-mediated EGFR signaling suppresses tumorigenicity in breast cancer cells. Cancer Research. 73: 530-530. DOI: 10.1158/1538-7445.Am2013-530 |
0.588 |
|
| 2013 |
Irish JC, Liu G, Ethier SP. Abstract 2964: Epigenetic mechanisms of transformation by WHSC1L1 in breast cancer cells with the 8p11-p12 amplicon. Cancer Research. 73: 2964-2964. DOI: 10.1158/1538-7445.Am2013-2964 |
0.585 |
|
| 2012 |
Holm K, Grabau D, Lövgren K, Aradottir S, Gruvberger-Saal S, Howlin J, Saal LH, Ethier SP, Bendahl PO, Stål O, Malmström P, Fernö M, Rydén L, Hegardt C, Borg Å, et al. Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes. Molecular Oncology. 6: 494-506. PMID 22766277 DOI: 10.1016/J.Molonc.2012.06.002 |
0.51 |
|
| 2012 |
Wang G, Liu G, Wang X, Sethi S, Ali-Fehmi R, Abrams J, Zheng Z, Zhang K, Ethier S, Yang ZQ. ERLIN2 promotes breast cancer cell survival by modulating endoplasmic reticulum stress pathways. Bmc Cancer. 12: 225. PMID 22681620 DOI: 10.1186/1471-2407-12-225 |
0.519 |
|
| 2012 |
Piechocki MP, Wu GS, Jones RF, Jacob JB, Gibson H, Ethier SP, Abrams J, Yagita H, Venuprasad K, Wei WZ. Induction of proapoptotic antibodies to triple-negative breast cancer by vaccination with TRAIL death receptor DR5 DNA. International Journal of Cancer. Journal International Du Cancer. 131: 2562-72. PMID 22419388 DOI: 10.1002/Ijc.27534 |
0.38 |
|
| 2012 |
Guest S, Haddad R, Gray J, Ethier S. Abstract 5125: Functional genomic strategies to identify oncogenes in breast cancer Cancer Research. 72: 5125-5125. DOI: 10.1158/1538-7445.Am2012-5125 |
0.493 |
|
| 2012 |
Atikukke G, Haddad R, Ethier SP. Abstract 5099: Identification of complex oncogene signatures in human cancer specimens and cell lines Cancer Research. 72: 5099-5099. DOI: 10.1158/1538-7445.Am2012-5099 |
0.498 |
|
| 2012 |
Varughese BE, Ethier SP. Abstract 3248: Amphiregulin interacts with Wnt signaling to regulate cancer cell growth and survival Cancer Research. 72: 3248-3248. DOI: 10.1158/1538-7445.Am2012-3248 |
0.545 |
|
| 2012 |
Hou J, Wu J, Dombkowski A, Boerner JL, Ethier S, Yang Z. Abstract 2192: Genomic amplification and drug-resistance roles of the KDM5A histone demethylase gene in breast cancer Cancer Research. 72: 2192-2192. DOI: 10.1158/1538-7445.Am2012-2192 |
0.539 |
|
| 2012 |
Irish JC, Ethier SP. Abstract 2190: Epigenetic mechanisms of transformation for the NSD3 oncogene in human breast cancer cells with the 8p11-p12 amplicon Cancer Research. 72: 2190-2190. DOI: 10.1158/1538-7445.Am2012-2190 |
0.591 |
|
| 2011 |
Fackler MJ, Umbricht CB, Williams D, Argani P, Cruz LA, Merino VF, Teo WW, Zhang Z, Huang P, Visvananthan K, Marks J, Ethier S, Gray JW, Wolff AC, Cope LM, et al. Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. Cancer Research. 71: 6195-207. PMID 21825015 DOI: 10.1158/0008-5472.Can-11-1630 |
0.466 |
|
| 2011 |
Wu J, Liu S, Liu G, Dombkowski A, Abrams J, Martin-Trevino R, Wicha MS, Ethier SP, Yang ZQ. Identification and functional analysis of 9p24 amplified genes in human breast cancer. Oncogene. 31: 333-41. PMID 21666724 DOI: 10.1038/Onc.2011.227 |
0.537 |
|
| 2011 |
Bollig-Fischer A, Dewey TG, Ethier SP. Oncogene activation induces metabolic transformation resulting in insulin-independence in human breast cancer cells. Plos One. 6: e17959. PMID 21437235 DOI: 10.1371/journal.pone.0017959 |
0.379 |
|
| 2011 |
Cote ML, Haddad R, Edwards DJ, Atikukke G, Gadgeel S, Soubani AO, Lonardo F, Bepler G, Schwartz AG, Ethier SP. Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 6: 627-30. PMID 21317742 DOI: 10.1097/Jto.0B013E31820A0Ec0 |
0.385 |
|
| 2011 |
Baillo A, Giroux C, Ethier SP. Knock-down of amphiregulin inhibits cellular invasion in inflammatory breast cancer. Journal of Cellular Physiology. 226: 2691-701. PMID 21302279 DOI: 10.1002/jcp.22620 |
0.495 |
|
| 2011 |
Zhang H, Meng F, Liu G, Zhang B, Zhu J, Wu F, Ethier SP, Miller F, Wu G. Forkhead transcription factor Foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis Cancer Research. 71: 1292-1301. PMID 21285253 DOI: 10.1158/0008-5472.Can-10-2825 |
0.521 |
|
| 2011 |
Wu J, Liu S, Liu G, Dombkowski A, Abrams J, Wicha M, Ethier S, Yang Z. Abstract 4700: Identification and functional analysis of 9p23-24 amplified genes in human breast cancer Cancer Research. 71: 4700-4700. DOI: 10.1158/1538-7445.Am2011-4700 |
0.594 |
|
| 2011 |
Zhang H, Meng F, Liu G, Zhang B, Zhu J, Wu F, Ethier SP, Miller F, Wu G. Abstract 3441: Cross-species expression profiling identifies Forkhead-Box Q1 as a promoter of epithelial-mesenchymal transition and breast cancer metastasis Cancer Research. 71: 3441-3441. DOI: 10.1158/1538-7445.Am2011-3441 |
0.475 |
|
| 2011 |
Liu G, Yang Z, Ethier SP. Abstract 1135: PPAPDC1B isoform 2, a new candidate oncogene within the 8p11-12 amplicon induces a proliferative advantage in breast cancer Cancer Research. 71: 1135-1135. DOI: 10.1158/1538-7445.Am2011-1135 |
0.612 |
|
| 2010 |
Yang ZQ, Liu G, Bollig-Fischer A, Giroux CN, Ethier SP. Transforming properties of 8p11-12 amplified genes in human breast cancer. Cancer Research. 70: 8487-97. PMID 20940404 DOI: 10.1158/0008-5472.Can-10-1013 |
0.529 |
|
| 2010 |
Bollig-Fischer A, Dziubinski M, Boyer A, Haddad R, Giroux CN, Ethier SP. HER-2 signaling, acquisition of growth factor independence, and regulation of biological networks associated with cell transformation. Cancer Research. 70: 7862-73. PMID 20736364 DOI: 10.1158/0008-5472.Can-10-1529 |
0.498 |
|
| 2010 |
Mueller KL, Yang ZQ, Haddad R, Ethier SP, Boerner JL. EGFR/Met association regulates EGFR TKI resistance in breast cancer. Journal of Molecular Signaling. 5: 8. PMID 20624308 DOI: 10.1186/1750-2187-5-8 |
0.543 |
|
| 2010 |
Zhang H, Chen D, Ringler J, Chen W, Cui QC, Ethier SP, Dou QP, Wu G. Disulfiram treatment facilitates phosphoinositide 3-kinase inhibition in human breast cancer cells in vitro and in vivo. Cancer Research. 70: 3996-4004. PMID 20424113 DOI: 10.1158/0008-5472.Can-09-3752 |
0.576 |
|
| 2010 |
Hollestelle A, Nagel JH, Smid M, Lam S, Elstrodt F, Wasielewski M, Ng SS, French PJ, Peeters JK, Rozendaal MJ, Riaz M, Koopman DG, Ten Hagen TL, de Leeuw BH, Zwarthoff EC, ... ... Ethier SP, et al. Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines. Breast Cancer Research and Treatment. 121: 53-64. PMID 19593635 DOI: 10.1007/S10549-009-0460-8 |
0.532 |
|
| 2010 |
Ethier SP, Atikkuke G, Haddad R. Identification of complex oncogene signatures in human cancer specimens and cell lines Clinical Cancer Research. 16. DOI: 10.1158/Diag-10-A27 |
0.471 |
|
| 2010 |
Wang G, Liu G, Ethier SP, Zhang K, Yang Z. Abstract 5022: Roles of endoplasmic reticulum factor ERLIN2 in malignancy maintenance and therapy resistance in breast cancer Cancer Research. 70: 5022-5022. DOI: 10.1158/1538-7445.Am10-5022 |
0.625 |
|
| 2010 |
Liu G, Yang Z, Ethier SP. Abstract 3102: Oncogenic PWWP-domain protein WHSC1L1 links the homeobox transcription factor IRX3 in breast cancer Cancer Research. 70: 3102-3102. DOI: 10.1158/1538-7445.Am10-3102 |
0.602 |
|
| 2010 |
Mueller KL, Haddad R, Yang Z, Ethier SP, Boerner JL. Abstract 278: Regulation of constitutive Met phosphorylation in breast cancer by EGFR Cancer Research. 70: 278-278. DOI: 10.1158/1538-7445.Am10-278 |
0.524 |
|
| 2010 |
Baillo AJ, Ethier SP. Abstract 267: The effect of amphiregulin knockdown on the expression of transformed phenotypes in triple-negative breast cancer Cancer Research. 70: 267-267. DOI: 10.1158/1538-7445.Am10-267 |
0.58 |
|
| 2010 |
Zhang H, Wu S, Wu F, Ethier SP, Miller F, Wu G. Abstract 2301: Cross-species expression profiling identifies novel genes differentially modulating epithelial-mesenchymal transition program and cell migration/invasion capability Cancer Research. 70: 2301-2301. DOI: 10.1158/1538-7445.Am10-2301 |
0.504 |
|
| 2010 |
Dykema KJ, Yang ZQ, Furge KA, Ethier SP, Haddad R. Abstract 117: jackTom, an algorithm to integrate aCGH and gene expression microarrays to predict activation of oncogenes by DNA amplification in individual tumors Cancer Research. 70: 117-117. DOI: 10.1158/1538-7445.Am10-117 |
0.371 |
|
| 2010 |
Bollig-Fischer AB, Ethier SP. Abstract 114: Identification of HER2 oncogene-regulated genes and pathways from dynamic gene expression data Cancer Research. 70: 114-114. DOI: 10.1158/1538-7445.Am10-114 |
0.537 |
|
| 2010 |
Nechiporchik N, Lieb K, Marquette L, Polin L, Peters G, Chen A, Ethier S, LoRusso P, Burger A. 189 Preclinical activity of the poly (ADP-ribose) polymerase (PARP) inhibitor ABT-888 in combination with irinotecan in ovarian and triple negative breast cancers European Journal of Cancer Supplements. 8: 64. DOI: 10.1016/S1359-6349(10)71894-2 |
0.379 |
|
| 2010 |
Lippman ME, Ethier S, Hayes DF. Erratum to: Editorial: Cost-effective analyses in Breast Cancer Research and Treatment Breast Cancer Research and Treatment. 129: 293-293. DOI: 10.1007/S10549-010-0743-0 |
0.431 |
|
| 2009 |
Liu G, Bollig-Fischer A, Kreike B, van de Vijver MJ, Abrams J, Ethier SP, Yang ZQ. Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer. Oncogene. 28: 4491-500. PMID 19784073 DOI: 10.1038/Onc.2009.297 |
0.606 |
|
| 2009 |
Yang ZQ, Liu G, Bollig-Fischer A, Haddad R, Tarca AL, Ethier SP. Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers. International Journal of Cancer. Journal International Du Cancer. 125: 1613-21. PMID 19569235 DOI: 10.1002/ijc.24518 |
0.538 |
|
| 2009 |
Lippman ME, Ethier S, Hayes DF. Editorial: Cost-effective analyses in Breast Cancer Research and Treatment [corrected]. Breast Cancer Research and Treatment. 115: 221-2. PMID 19449205 DOI: 10.1007/S10549-009-0414-1 |
0.399 |
|
| 2009 |
Arias-Romero LE, Saha S, Villamar-Cruz O, Yip SC, Ethier SP, Zhang ZY, Chernoff J. Activation of Src by protein tyrosine phosphatase 1B Is required for ErbB2 transformation of human breast epithelial cells. Cancer Research. 69: 4582-8. PMID 19435911 DOI: 10.1158/0008-5472.Can-08-4001 |
0.578 |
|
| 2009 |
Willmarth NE, Baillo A, Dziubinski ML, Wilson K, Riese DJ, Ethier SP. Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop. Cellular Signalling. 21: 212-9. PMID 18951974 DOI: 10.1016/J.Cellsig.2008.10.003 |
0.776 |
|
| 2009 |
Wasielewski M, Hanifi-Moghaddam P, Hollestelle A, Merajver SD, van den Ouweland A, Klijn JG, Ethier SP, Schutte M. Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines. Breast Cancer Research and Treatment. 113: 285-91. PMID 18297428 DOI: 10.1007/S10549-008-9942-3 |
0.479 |
|
| 2009 |
Bollig A, Giroux C, Dewey T, Ethier S. HER-2 over expression mediates the transition to aerobic glycolysis and stress/REDOX signaling in progressively transformed human mammary epithelial cells. Cancer Research. 69: 6032. DOI: 10.1158/0008-5472.Sabcs-6032 |
0.455 |
|
| 2008 |
Balan V, Nangia-Makker P, Schwartz AG, Jung YS, Tait L, Hogan V, Raz T, Wang Y, Yang ZQ, Wu GS, Guo Y, Li H, Abrams J, Couch FJ, Lingle WL, ... ... Ethier SP, et al. Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): a pilot study. Cancer Research. 68: 10045-50. PMID 19074869 DOI: 10.1158/0008-5472.Can-08-3224 |
0.488 |
|
| 2008 |
Riggins RB, Lan JP, Zhu Y, Klimach U, Zwart A, Cavalli LR, Haddad BR, Chen L, Gong T, Xuan J, Ethier SP, Clarke R. ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer. Cancer Research. 68: 8908-17. PMID 18974135 DOI: 10.1158/0008-5472.Can-08-2669 |
0.539 |
|
| 2008 |
Mueller KL, Hunter LA, Ethier SP, Boerner JL. Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells. Cancer Research. 68: 3314-22. PMID 18451158 DOI: 10.1158/0008-5472.Can-08-0132 |
0.51 |
|
| 2008 |
Willmarth NE, Ethier SP. Amphiregulin as a novel target for breast cancer therapy. Journal of Mammary Gland Biology and Neoplasia. 13: 171-9. PMID 18437539 DOI: 10.1007/S10911-008-9081-9 |
0.775 |
|
| 2008 |
Zhang H, Liu G, Dziubinski M, Yang Z, Ethier SP, Wu G. Comprehensive analysis of oncogenic effects of PIK3CA mutations in human mammary epithelial cells. Breast Cancer Research and Treatment. 112: 217-27. PMID 18074223 DOI: 10.1007/S10549-007-9847-6 |
0.536 |
|
| 2008 |
Saal LH, Gruvberger-Saal SK, Persson C, Lövgren K, Jumppanen M, Staaf J, Jönsson G, Pires MM, Maurer M, Holm K, Koujak S, Subramaniyam S, Vallon-Christersson J, Olsson H, Su T, ... ... Ethier SP, et al. Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nature Genetics. 40: 102-7. PMID 18066063 DOI: 10.1038/Ng.2007.39 |
0.484 |
|
| 2007 |
Streicher KL, Willmarth NE, Garcia J, Boerner JL, Dewey TG, Ethier SP. Activation of a nuclear factor kappaB/interleukin-1 positive feedback loop by amphiregulin in human breast cancer cells. Molecular Cancer Research : McR. 5: 847-61. PMID 17670913 DOI: 10.1158/1541-7786.Mcr-06-0427 |
0.761 |
|
| 2007 |
Diehl KM, Grewal N, Ethier SP, Woods-Ignatoski KM. p38MAPK-activated AKT in HER-2 overexpressing human breast cancer cells acts as an EGF-independent survival signal. The Journal of Surgical Research. 142: 162-9. PMID 17612563 DOI: 10.1016/J.Jss.2007.01.025 |
0.539 |
|
| 2007 |
Yang ZQ, Moffa AB, Haddad R, Streicher KL, Ethier SP. Transforming properties of TC-1 in human breast cancer: interaction with FGFR2 and beta-catenin signaling pathways. International Journal of Cancer. Journal International Du Cancer. 121: 1265-73. PMID 17520678 DOI: 10.1002/Ijc.22831 |
0.807 |
|
| 2007 |
Wu G, Guo Z, Chang X, Kim MS, Nagpal JK, Liu J, Maki JM, Kivirikko KI, Ethier SP, Trink B, Sidransky D. LOXL1 and LOXL4 are epigenetically silenced and can inhibit ras/extracellular signal-regulated kinase signaling pathway in human bladder cancer. Cancer Research. 67: 4123-9. PMID 17456585 DOI: 10.1158/0008-5472.Can-07-0012 |
0.451 |
|
| 2007 |
Moffa AB, Ethier SP. Differential signal transduction of alternatively spliced FGFR2 variants expressed in human mammary epithelial cells. Journal of Cellular Physiology. 210: 720-31. PMID 17133345 DOI: 10.1002/Jcp.20880 |
0.784 |
|
| 2007 |
Streicher KL, Yang ZQ, Draghici S, Ethier SP. Transforming function of the LSM1 oncogene in human breast cancers with the 8p11-12 amplicon Oncogene. 26: 2104-2114. PMID 17001308 DOI: 10.1038/Sj.Onc.1210002 |
0.634 |
|
| 2006 |
Yang ZQ, Streicher KL, Ray ME, Abrams J, Ethier SP. Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer. Cancer Research. 66: 11632-43. PMID 17178857 DOI: 10.1158/0008-5472.CAN-06-2946 |
0.473 |
|
| 2006 |
Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, Speed T, Spellman PT, DeVries S, Lapuk A, Wang NJ, ... ... Ethier S, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 10: 515-27. PMID 17157791 DOI: 10.1016/J.Ccr.2006.10.008 |
0.547 |
|
| 2006 |
Willmarth NE, Ethier SP. Autocrine and juxtacrine effects of amphiregulin on the proliferative, invasive, and migratory properties of normal and neoplastic human mammary epithelial cells. The Journal of Biological Chemistry. 281: 37728-37. PMID 17035230 DOI: 10.1074/Jbc.M606532200 |
0.781 |
|
| 2006 |
Hayes DF, Ethier S, Lippman ME. New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK. Breast Cancer Research and Treatment. 100: 237-8. PMID 16773436 DOI: 10.1007/S10549-006-9253-5 |
0.446 |
|
| 2006 |
Pal M, Moffa A, Sreekumar A, Ethier SP, Barder TJ, Chinnaiyan A, Lubman DM. Differential phosphoprotein mapping in cancer cells using protein microarrays produced from 2-D liquid fractionation. Analytical Chemistry. 78: 702-10. PMID 16448042 DOI: 10.1021/Ac0511243 |
0.761 |
|
| 2006 |
Elstrodt F, Hollestelle A, Nagel JH, Gorin M, Wasielewski M, van den Ouweland A, Merajver SD, Ethier SP, Schutte M. BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. Cancer Research. 66: 41-5. PMID 16397213 DOI: 10.1158/0008-5472.Can-05-2853 |
0.48 |
|
| 2005 |
Gelsi-Boyer V, Orsetti B, Cervera N, Finetti P, Sircoulomb F, Rougé C, Lasorsa L, Letessier A, Ginestier C, Monville F, Esteyriès S, Adélaïde J, Esterni B, Henry C, Ethier SP, et al. Comprehensive profiling of 8p11-12 amplification in breast cancer. Molecular Cancer Research : McR. 3: 655-67. PMID 16380503 DOI: 10.1158/1541-7786.Mcr-05-0128 |
0.462 |
|
| 2005 |
Woods Ignatoski KM, Dziubinski ML, Ammerman C, Ethier SP. Cooperative interactions of HER-2 and HPV-16 oncoproteins in the malignant transformation of human mammary epithelial cells. Neoplasia (New York, N.Y.). 7: 788-98. PMID 16207481 DOI: 10.1593/Neo.05106 |
0.469 |
|
| 2005 |
Berquin IM, Pang B, Dziubinski ML, Scott LM, Chen YQ, Nolan GP, Ethier SP. Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells. Oncogene. 24: 3177-86. PMID 15735691 DOI: 10.1038/Sj.Onc.1208504 |
0.549 |
|
| 2004 |
Jia Y, Zeng ZZ, Markwart SM, Rockwood KF, Ignatoski KM, Ethier SP, Livant DL. Integrin fibronectin receptors in matrix metalloproteinase-1-dependent invasion by breast cancer and mammary epithelial cells. Cancer Research. 64: 8674-81. PMID 15574776 DOI: 10.1158/0008-5472.Can-04-0069 |
0.521 |
|
| 2004 |
Moffa AB, Tannheimer SL, Ethier SP. Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells. Molecular Cancer Research : McR. 2: 643-52. PMID 15561780 |
0.806 |
|
| 2004 |
Yang ZQ, Albertson D, Ethier SP. Genomic organization of the 8p11-p12 amplicon in three breast cancer cell lines. Cancer Genetics and Cytogenetics. 155: 57-62. PMID 15527903 DOI: 10.1016/J.Cancergencyto.2004.03.013 |
0.471 |
|
| 2004 |
Rios-Doria J, Kuefer R, Ethier SP, Day ML. Cleavage of beta-catenin by calpain in prostate and mammary tumor cells. Cancer Research. 64: 7237-40. PMID 15492240 DOI: 10.1158/0008-5472.Can-04-1048 |
0.404 |
|
| 2004 |
Willmarth NE, Albertson DG, Ethier SP. Chromosomal instability and lack of cyclin E regulation in hCdc4 mutant human breast cancer cells. Breast Cancer Research : Bcr. 6: R531-9. PMID 15318934 DOI: 10.1186/Bcr900 |
0.772 |
|
| 2004 |
Nyati MK, Maheshwari D, Hanasoge S, Sreekumar A, Rynkiewicz SD, Chinnaiyan AM, Leopold WR, Ethier SP, Lawrence TS. Radiosensitization by pan ErbB inhibitor CI-1033 in vitro and in vivo. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 691-700. PMID 14760092 DOI: 10.1158/1078-0432.Ccr-1041-03 |
0.373 |
|
| 2004 |
Ray ME, Yang ZQ, Albertson D, Kleer CG, Washburn JG, Macoska JA, Ethier SP. Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines. Cancer Research. 64: 40-7. PMID 14729606 DOI: 10.1158/0008-5472.Can-03-1022 |
0.564 |
|
| 2004 |
Song H, Ethier SP, Dziubinski ML, Lin J. Stat3 modulates heat shock 27kDa protein expression in breast epithelial cells. Biochemical and Biophysical Research Communications. 314: 143-50. PMID 14715258 DOI: 10.1016/J.Bbrc.2003.12.048 |
0.55 |
|
| 2003 |
Ethier SP. Identifying and validating causal genetic alterations in human breast cancer. Breast Cancer Research and Treatment. 78: 285-7. PMID 12755487 DOI: 10.1023/A:1023078722316 |
0.522 |
|
| 2003 |
Woods Ignatoski KM, Livant DL, Markwart S, Grewal NK, Ethier SP. The role of phosphatidylinositol 3'-kinase and its downstream signals in erbB-2-mediated transformation. Molecular Cancer Research : McR. 1: 551-60. PMID 12754302 |
0.381 |
|
| 2003 |
Woods Ignatoski KM, Grewal NK, Markwart S, Livant DL, Ethier SP. p38MAPK induces cell surface alpha4 integrin downregulation to facilitate erbB-2-mediated invasion. Neoplasia (New York, N.Y.). 5: 128-34. PMID 12659685 DOI: 10.1016/S1476-5586(03)80004-0 |
0.411 |
|
| 2003 |
Kumar-Sinha C, Ignatoski KW, Lippman ME, Ethier SP, Chinnaiyan AM. Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Research. 63: 132-9. PMID 12517789 |
0.486 |
|
| 2003 |
Ethier S, Allen A. CI-1033 An pan Erb-b tyrosine kinase inhibitor (TKI) induces apoptosis and radiosenstization in human glioblastoma cells International Journal of Radiation Oncology*Biology*Physics. 57: S295. DOI: 10.1016/S0360-3016(03)01155-6 |
0.33 |
|
| 2002 |
Popovici C, Basset C, Bertucci F, Orsetti B, Adélaide J, Mozziconacci MJ, Conte N, Murati A, Ginestier C, Charafe-Jauffret E, Ethier SP, Lafage-Pochitaloff M, Theillet C, Birnbaum D, Chaffanet M. Reciprocal translocations in breast tumor cell lines: cloning of a t(3;20) that targets the FHIT gene. Genes, Chromosomes & Cancer. 35: 204-18. PMID 12353263 DOI: 10.1002/Gcc.10107 |
0.497 |
|
| 2002 |
Ethier SP. Signal transduction pathways: the molecular basis for targeted therapies. Seminars in Radiation Oncology. 12: 3-10. PMID 12174339 DOI: 10.1053/Srao.2002.34863 |
0.466 |
|
| 2002 |
Billecke CA, Ljungman ME, McKay BC, Rehemtulla A, Taneja N, Ethier SP. Lack of functional pRb results in attenuated recovery of mRNA synthesis and increased apoptosis following UV radiation in human breast cancer cells. Oncogene. 21: 4481-9. PMID 12085226 DOI: 10.1038/Sj.Onc.1205546 |
0.405 |
|
| 2001 |
Berquin IM, Dziubinski ML, Nolan GP, Ethier SP. A functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin Oncogene. 20: 4019-4028. PMID 11494130 DOI: 10.1038/Sj.Onc.1204537 |
0.599 |
|
| 2001 |
Ethier SP, Lawrence TS. Epidermal growth factor receptor signaling and response of cancer cells to ionizing radiation. Journal of the National Cancer Institute. 93: 890-1. PMID 11416102 DOI: 10.1093/Jnci/93.12.890 |
0.443 |
|
| 2001 |
Sartor CI, Zhou H, Kozlowska E, Guttridge K, Kawata E, Caskey L, Harrelson J, Hynes N, Ethier S, Calvo B, Earp HS. Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells. Molecular and Cellular Biology. 21: 4265-75. PMID 11390655 DOI: 10.1128/Mcb.21.13.4265-4275.2001 |
0.563 |
|
| 2001 |
Chong BE, Hamler RL, Lubman DM, Ethier SP, Rosenspire AJ, Miller FR. Differential screening and mass mapping of proteins from premalignant and cancer cell lines using nonporous reversed-phase HPLC coupled with mass spectrometric analysis. Analytical Chemistry. 73: 1219-27. PMID 11305655 DOI: 10.1021/Ac001066F |
0.38 |
|
| 2001 |
Rao GS, Murray S, Ethier SP. Radiosensitization of human breast cancer cells by a novel ErbB family receptor tyrosine kinase inhibitor. International Journal of Radiation Oncology, Biology, Physics. 48: 1519-28. PMID 11121658 DOI: 10.1016/S0360-3016(00)01358-4 |
0.537 |
|
| 2001 |
Percy MJ, Myrie KA, Neeley CK, Azim JN, Ethier SP, Petty EM. Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells. Genes, Chromosomes & Cancer. 29: 356-62. PMID 11066082 DOI: 10.1002/1098-2264(2000)9999:9999<::Aid-Gcc1044>3.0.Co;2-N |
0.597 |
|
| 2000 |
Tannheimer SL, Rehemtulla A, Ethier SP. Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE. Breast Cancer Research : Bcr. 2: 311-20. PMID 11056689 DOI: 10.1186/Bcr73 |
0.634 |
|
| 2000 |
Carlson CA, Ethier SP. Lack of RB protein correlates with increased sensitivity to UV-radiation-induced apoptosis in human breast cancer cells. Radiation Research. 154: 590-9. PMID 11025655 DOI: 10.1667/0033-7587(2000)154[0590:Lorpcw]2.0.Co;2 |
0.499 |
|
| 2000 |
Sumantran VN, Lee DS, Woods Ignatoski KM, Ethier SP, Wicha MS. A bcl-xS adenovirus selectively induces apoptosis in transformed cells compared to normal mammary cells. Neoplasia (New York, N.Y.). 2: 251-60. PMID 10935511 DOI: 10.1038/SJ.NEO.7900084 |
0.321 |
|
| 2000 |
Ethier SP. Human breast cancer cell lines as models of growth regulation and disease progression. Journal of Mammary Gland Biology and Neoplasia. 1: 111-21. PMID 10887484 DOI: 10.1007/Bf02096306 |
0.591 |
|
| 2000 |
Ram TG, Hosick HL, Ethier SP. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells. Journal of Cellular Physiology. 183: 301-13. PMID 10797304 DOI: 10.1002/(Sici)1097-4652(200006)183:3<301::Aid-Jcp2>3.0.Co;2-W |
0.475 |
|
| 2000 |
Flanagan L, Van Weelden K, Ammerman C, Ethier SP, Welsh J. SUM-159PT cells: a novel estrogen independent human breast cancer model system. Breast Cancer Research and Treatment. 58: 193-204. PMID 10718481 DOI: 10.1023/A:1006331716981 |
0.455 |
|
| 2000 |
Ignatoski KM, Maehama T, Markwart SM, Dixon JE, Livant DL, Ethier SP. ERBB-2 overexpression confers PI 3' kinase-dependent invasion capacity on human mammary epithelial cells. British Journal of Cancer. 82: 666-74. PMID 10682681 DOI: 10.1054/Bjoc.1999.0979 |
0.594 |
|
| 1999 |
Axelson MD, Davis MA, Ethier SP, Lawrence TS. HPV16-E7 expression causes fluorodeoxyuridine-mediated radiosensitization in SW620 human colon cancer cells. Neoplasia (New York, N.Y.). 1: 177-82. PMID 10933053 DOI: 10.1038/Sj.Neo.7900012 |
0.423 |
|
| 1999 |
Ignatoski KM, Lapointe AJ, Radany EH, Ethier SP. erbB-2 overexpression in human mammary epithelial cells confers growth factor independence. Endocrinology. 140: 3615-22. PMID 10433219 DOI: 10.1210/Endo.140.8.6939 |
0.561 |
|
| 1999 |
Ignatoski KM, Ethier SP. Constitutive activation of pp125fak in newly isolated human breast cancer cell lines. Breast Cancer Research and Treatment. 54: 173-82. PMID 10424408 DOI: 10.1023/A:1006135331912 |
0.601 |
|
| 1999 |
Rao G, Ethier S. 30 Potentiation of radiation-induced breast cancer cell death by inhibition of epidermal growth factor family of receptors International Journal of Radiation Oncology*Biology*Physics. 45: 162. DOI: 10.1016/S0360-3016(99)90048-2 |
0.408 |
|
| 1998 |
Tannheimer SL, Ethier SP, Caldwell KK, Burchiel SW. Benzo[a]pyrene- and TCDD-induced alterations in tyrosine phosphorylation and insulin-like growth factor signaling pathways in the MCF-10A human mammary epithelial cell line. Carcinogenesis. 19: 1291-7. PMID 9683191 DOI: 10.1093/Carcin/19.7.1291 |
0.418 |
|
| 1997 |
Tannheimer SL, Barton SL, Ethier SP, Burchiel SW. Carcinogenic polycyclic aromatic hydrocarbons increase intracellular Ca2+ and cell proliferation in primary human mammary epithelial cells. Carcinogenesis. 18: 1177-82. PMID 9214600 DOI: 10.1093/Carcin/18.6.1177 |
0.321 |
|
| 1996 |
Ethier SP, Langton BC, Dilts CA. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha. Molecular Carcinogenesis. 15: 134-43. PMID 8599580 DOI: 10.1002/(Sici)1098-2744(199602)15:2<134::Aid-Mc6>3.0.Co;2-J |
0.424 |
|
| 1996 |
Ram TG, Dilts CA, Dziubinski ML, Pierce LJ, Ethier SP. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2. Molecular Carcinogenesis. 15: 227-38. PMID 8597535 DOI: 10.1002/(Sici)1098-2744(199603)15:3<227::Aid-Mc8>3.0.Co;2-E |
0.527 |
|
| 1995 |
Ram TG, Kokeny KE, Dilts CA, Ethier SP. Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-I in human mammary epithelial cells. Journal of Cellular Physiology. 163: 589-96. PMID 7775601 DOI: 10.1002/Jcp.1041630320 |
0.52 |
|
| 1995 |
Ethier SP. Growth factor synthesis and human breast cancer progression. Journal of the National Cancer Institute. 87: 964-73. PMID 7629883 DOI: 10.1093/Jnci/87.13.964 |
0.594 |
|
| 1995 |
Rock CL, Ethier SP, Kusluski RA, Galvez MM. Carotenoids Induce Morphological Changes in Human Mammary Epithelial Cell Cultures Nutrition and Cancer. 23: 319-333. PMID 7603892 DOI: 10.1080/01635589509514386 |
0.463 |
|
| 1995 |
Rachwal WJ, Bongiorno PF, Orringer MB, Whyte RI, Ethier SP, Beer DG. Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas. British Journal of Cancer. 72: 56-64. PMID 7599067 DOI: 10.1038/Bjc.1995.277 |
0.501 |
|
| 1994 |
Ethier SP, Taback E. Insulin like growth factor-I independence in rat mammary carcinoma cells: a dominant phenotype in somatic cell hybrid experiments. Cancer Letters. 74: 189-95. PMID 8174103 DOI: 10.1016/0304-3835(93)90242-2 |
0.408 |
|
| 1994 |
Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, Roth MS. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction Journal of Clinical Oncology. 12: 475-482. PMID 7509852 DOI: 10.1200/Jco.1994.12.3.475 |
0.453 |
|
| 1993 |
Mahacek ML, Beer DG, Frank TS, Ethier SP. Finite proliferative lifespan in vitro of a human breast cancer cell strain isolated from a metastatic lymph node. Breast Cancer Research and Treatment. 28: 267-76. PMID 8018955 DOI: 10.1007/Bf00666588 |
0.59 |
|
| 1993 |
Ethier SP, Dilts CM, Pierce LJ, Kokeny K, Mahacek M. Identification of altered growth phenotypes in human breast cancer cells using cell culture methods that support growth of normal and neoplastic mammary epithelial cells Journal of Cellular Biochemistry. 53: 251-251. DOI: 10.1002/Jcb.240531151 |
0.604 |
|
| 1991 |
Ethier SP, Moorthy R. Multiple growth factor independence in rat mammary carcinoma cells. Breast Cancer Research and Treatment. 18: 73-81. PMID 1912610 DOI: 10.1007/Bf01980969 |
0.419 |
|
| 1991 |
Chiodino C, Jones RF, Ethier SP. The role of Ha-ras oncogenes in growth factor independence in rat mammary carcinoma cells. Molecular Carcinogenesis. 4: 286-96. PMID 1908245 DOI: 10.1002/Mc.2940040407 |
0.369 |
|
| 1991 |
Ethier SP, Summerfelt RM, Cundiff KC, Asch BB. The influence of growth factors on the proliferative potential of normal and primary breast cancer-derived human breast epithelial cells. Breast Cancer Research and Treatment. 17: 221-30. PMID 1710154 DOI: 10.1007/Bf01806371 |
0.446 |
|
| 1990 |
Ethier SP, Velde RMVD. Secretion of a TGF-β-like growth inhibitor by normal rat mammary epithelial cells in vitro Journal of Cellular Physiology. 142: 15-20. PMID 2298817 DOI: 10.1002/Jcp.1041420103 |
0.383 |
|
| 1989 |
Ethier SP, van de Velde RM, Cundiff KC. cAMP levels in proliferating rat mammary epithelial cells in vitro and in vivo. Experimental Cell Research. 182: 653-8. PMID 2542072 DOI: 10.1016/0014-4827(89)90267-X |
0.385 |
|
| 1987 |
Ethier SP, Kudla A, Cundiff KC. Influence of hormone and growth factor interactions on the proliferative potential of normal rat mammary epithelial cells in vitro. Journal of Cellular Physiology. 132: 161-7. PMID 2439521 DOI: 10.1002/Jcp.1041320123 |
0.4 |
|
| 1985 |
Ethier SP. Primary Culture and Serial Passage of Normal and Carcinogen-Treated Rat Mammary Epithelial Cells In Vitro Journal of the National Cancer Institute. 74: 1307-1318. DOI: 10.1093/Jnci/74.6.1307 |
0.389 |
|
| Show low-probability matches. |